DOF's bio business was launched to recognize the reality of domestic patients suffering from the deactivation
of the domestic tissue donation culture, the transplanted tissue business dependent on the importer,
and the lack of supply of turnover tissue, and to provide even a small help.
We, DOF, have been striving to provide the best eco-friendly products and solutions based on supercritical
biomaterial technology through heterogeneous fusion of chemical engineering and biotechnology
for the stable supply of domestic transplant tissues, and we are making progress little by little.

Based on these results, we develop various bio products such as human tissue for transplantation, cartilage treatment,
tissue-based exosomes, human fat-derived fillers, and tissue-based medical devices,
while expanding our business to the next-generation bio field by providing differentiated solutions.
DOF has been conducting safety and efficacy audits several times to ensure perfection
in each product in order to prevent side effects that may occur at any time through various cooperation
with medical specialists and clinical experts from related medical institutions.

At the same time as non-clinical/clinical trials, we acquire tissue bank processing business and
GMP facilities to present optimal health and life to domestic and even global customers more effectively and safely.

Our DOF's executives and employees promise to provide products
and services of the world's highest value by growing into a business entity that improves the quality
of mankind with all our enthusiasm and sincerity.
Thank you